XML 28 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets, Net
 3 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill were as follows:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
European Pharmaceutical Solutions
 
Medical-Surgical Solutions
 
Other
 
Total
Balance, March 31, 2018
$
4,110

 
$
1,850

 
$
2,070

 
$
2,894

 
$
10,924

Goodwill acquired
—

 
31

 
360

 
—

 
391

Goodwill impairment charges
—

 
(570
)
 
—

 
—

 
(570
)
Acquisition accounting, transfers and other adjustments
4

 
—

 
—

 
6

 
10

Foreign currency translation adjustments, net
(36
)
 
(98
)
 
—

 
(36
)
 
(170
)
Balance, June 30, 2018
$
4,078

 
$
1,213

 
$
2,430

 
$
2,864

 
$
10,585


As of June 30, 2018, accumulated goodwill impairment losses were $1,793 million and $448 million in our European Pharmaceutical Solutions segment and Other. As of March 31, 2018, accumulated goodwill impairment losses were $1,299 million and $456 million in our European Pharmaceutical segment and Other. Refer to Financial Note 3, “Goodwill Impairment Charges,” for more information on goodwill impairment charges recorded in the first quarter of 2019.
Information regarding intangible assets is as follows:
 
June 30, 2018
 
March 31, 2018
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships
13
 
$
4,038

 
$
(1,724
)
 
$
2,314

 
$
3,619

 
$
(1,550
)
 
$
2,069

Service agreements
12
 
1,020

 
(392
)
 
628

 
1,037

 
(386
)
 
651

Pharmacy licenses
25
 
766

 
(336
)
 
430

 
684

 
(196
)
 
488

Trademarks and trade names
14
 
938

 
(207
)
 
731

 
932

 
(187
)
 
745

Technology
4
 
146

 
(87
)
 
59

 
147

 
(84
)
 
63

Other
5
 
285

 
(189
)
 
96

 
262

 
(176
)
 
86

Total
 
 
$
7,193


$
(2,935
)
 
$
4,258

 
$
6,681

 
$
(2,579
)
 
$
4,102


Amortization expense of intangible assets was $122 million and $121 million for the quarters ended June 30, 2018 and 2017. Estimated annual amortization expense of these assets is as follows: $344 million, $441 million, $423 million, $391 million and $282 million for the remainder of 2019 and each of the succeeding years through 2023 and $2,377 million thereafter. All intangible assets were subject to amortization as of June 30, 2018 and March 31, 2018.